Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SKODSBORG FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.4% 1.9% 0.9% 1.0% 1.4% 0.9% 7.1% 6.9%   Credit score (0-100)   80 72 89 86 78 87 34 35   Credit rating   A A A A A A BBB BBB   Credit limit (kDKK)   30.1 0.8 321.3 221.1 32.6 292.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,791 6,398 7,002 6,110 6,278 6,025 0.0 0.0   EBITDA   347 -473 1,145 304 -134 74.8 0.0 0.0   EBIT   34.0 -797 1,106 105 -154 -89.3 0.0 0.0   Pre-tax profit (PTP)   -14.2 -622.5 1,295.0 381.2 269.5 351.4 0.0 0.0   Net earnings   -40.5 -500.6 1,029.9 289.1 193.2 275.6 0.0 0.0   Pre-tax profit without non-rec. items   -176 -622 1,295 381 270 351 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   465 271 125 46.3 473 797 0.0 0.0   Shareholders equity total   1,676 1,175 2,205 2,494 2,687 2,963 2,763 2,763   Interest-bearing liabilities   1,153 113 0.0 0.0 553 1,299 0.0 0.0   Balance sheet total (assets)   4,858 4,725 5,207 5,259 7,054 7,463 2,763 2,763   Net Debt   -402 -1,022 -1,573 -829 177 1,024 -2,713 -2,713     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,791 6,398 7,002 6,110 6,278 6,025 0.0 0.0   Gross profit growth   0.8% -17.9% 9.4% -12.7% 2.7% -4.0% -100.0% 0.0%   Employees   0 0 0 0 0 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,858 4,725 5,207 5,259 7,054 7,463 2,763 2,763   Balance sheet change%   -1.4% -2.7% 10.2% 1.0% 34.1% 5.8% -63.0% 0.0%   Added value   347.0 -553.9 1,252.3 184.1 -75.6 74.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -576 -438 -292 -157 407 160 -797 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.4% -12.5% 15.8% 1.7% -2.5% -1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.7% -10.7% 26.6% 7.4% 4.7% 6.3% 0.0% 0.0%   ROI %   2.7% -19.9% 54.0% 14.3% 9.2% 11.2% 0.0% 0.0%   ROE %   -2.4% -35.1% 60.9% 12.3% 7.5% 9.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   34.5% 24.9% 42.3% 47.4% 38.1% 39.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -115.8% 215.9% -137.4% -272.5% -132.0% 1,369.0% 0.0% 0.0%   Gearing %   68.8% 9.6% 0.0% 0.0% 20.6% 43.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.8% 17.0% 45.2% 0.0% 7.8% 11.3% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.9 1.6 1.7 1.9 1.4 1.4 0.0 0.0   Current Ratio   1.9 1.6 1.7 1.9 1.4 1.4 0.0 0.0   Cash and cash equivalent   1,554.7 1,135.1 1,573.4 828.5 376.2 275.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,223.0 736.2 1,128.0 1,509.6 1,447.7 1,540.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 11 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 11 0 0   EBIT / employee   0 0 0 0 0 -13 0 0   Net earnings / employee   0 0 0 0 0 39 0 0